KRYS KRYSTAL BIOTECH INC

Ownership history in Frazier Life Sciences Management, L.P.  ·  16 quarters on record

AI Ownership Summary

Frazier Life Sciences Management, L.P. reported KRYSTAL BIOTECH INC (KRYS) in 16 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 8.49% in 2024 Q2. The latest visible filing shows KRYS at 3.23% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this KRYS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Frazier Life Sciences Management, L.P.'s position in KRYSTAL BIOTECH INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

KRYS was reported at 3.23% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
8.49% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Frazier Life Sciences Management, L.P. held KRYS — position size vs. price
% of Fund (quarterly)    KRYS price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 488,460 -200,000 -29.1% 3.23% $120.4M 2026-02-14 (Est.) $276.45
2025 Q3 UNCHANGED 688,460 0% 3.64% $121.5M 2025-11-14 $206.16
2025 Q2 UNCHANGED 688,460 0% 3.78% $94.6M 2025-08-14 $150.33
2025 Q1 REDUCED 688,460 -100,000 -12.7% 5.67% $124.1M 2025-05-15 $130.33
2024 Q4 REDUCED 788,460 -200,000 -20.2% 5.13% $123.5M 2025-02-18 $156.69
2024 Q3 UNCHANGED 988,460 0% 7.21% $179.9M 2024-11-15 $170.74
2024 Q2 UNCHANGED 988,460 0% 8.49% $181.5M 2024-08-15 $193.98
2024 Q1 UNCHANGED 988,460 0% 7.42% $175.9M 2024-05-15 $163.19
2023 Q4 UNCHANGED 988,460 0% 6.56% $122.6M 2024-02-14 $110.13
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Frazier Life Sciences Management, L.P. and KRYS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Frazier Life Sciences Management, L.P. reported owning KRYS?

Frazier Life Sciences Management, L.P. reported KRYS across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported KRYS position in Frazier Life Sciences Management, L.P.'s portfolio?

The largest reported portfolio weight for KRYS was 8.49% in 2024 Q2.

What is the latest reported KRYS position on this page?

The most recent filing on this page is 2025 Q4, when Frazier Life Sciences Management, L.P. reported 488,460 shares, equal to 3.23% of portfolio, with an estimated market value of $120.4M.

What does the chart on this KRYS ownership page compare?

The chart compares Frazier Life Sciences Management, L.P.'s quarterly KRYS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Frazier Life Sciences Management, L.P. Holdings